Loading...
Nano-X Imaging Ltd.
NNOX•NASDAQ
Healthcare
Medical - Devices
$5.20
$0.00(0.00%)
Nano-X Imaging Ltd. (NNOX) Financial Performance & Income Statement Overview
Review Nano-X Imaging Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.91%
↑ 13.91%
Operating Income Growth
9.34%
↑ 9.34%
Net Income Growth
11.95%
↑ 11.95%
Operating Cash Flow Growth
18.27%
↑ 18.27%
Operating Margin
-499.88%
↓ 499.88%
Gross Margin
-100.51%
↓ 100.51%
Net Profit Margin
-472.19%
↓ 472.19%
ROE
-30.92%
↓ 30.92%
ROIC
-31.38%
↓ 31.38%
Nano-X Imaging Ltd. (NNOX) Income Statement & Financial Overview
Review Nano-X Imaging Ltd.'s (NNOX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.00M | $3.03M | $2.70M | $2.55M |
| Cost of Revenue | $5.89M | $5.84M | $5.55M | $4.70M |
| Gross Profit | -$2.89M | -$2.81M | -$2.85M | -$2.15M |
| Gross Profit Ratio | -$0.96 | -$0.93 | -$1.06 | -$0.84 |
| R&D Expenses | $5.40M | $4.75M | $4.81M | $5.22M |
| SG&A Expenses | $6.56M | $6.60M | $6.75M | $5.71M |
| Operating Expenses | $12.09M | $11.33M | $11.46M | $10.93M |
| Total Costs & Expenses | $17.98M | $17.17M | $17.21M | $15.64M |
| Interest Income | $820000.00 | $404000.00 | $856000.00 | $790000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.94M | $2.93M | $2.93M | $2.94M |
| EBITDA | -$12.04M | -$11.21M | -$11.54M | -$10.19M |
| EBITDA Ratio | -$4.01 | -$3.70 | -$4.27 | -$3.99 |
| Operating Income | -$14.97M | -$14.14M | -$14.51M | -$13.08M |
| Operating Income Ratio | -$4.99 | -$4.66 | -$5.37 | -$5.12 |
| Other Income/Expenses (Net) | $820000.00 | $406000.00 | $856000.00 | $790000.00 |
| Income Before Tax | -$14.15M | -$13.73M | -$13.65M | -$12.34M |
| Income Before Tax Ratio | -$4.72 | -$4.53 | -$5.06 | -$4.83 |
| Income Tax Expense | -$94000.00 | -$94000.00 | -$76000.00 | -$94000.00 |
| Net Income | -$14.06M | -$13.64M | -$13.57M | -$12.24M |
| Net Income Ratio | -$4.69 | -$4.50 | -$5.03 | -$4.79 |
| EPS | -$0.24 | -$0.23 | -$0.23 | -$0.21 |
| Diluted EPS | -$0.24 | -$0.23 | -$0.23 | -$0.21 |
| Weighted Avg Shares Outstanding | $60.14M | $58.62M | $58.005M | $57.90M |
| Weighted Avg Shares Outstanding (Diluted) | $60.14M | $58.62M | $58.005M | $57.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan